KCNH2 (potassium voltage-gated channel subfamily H member 2)

2007-02-01  

Identity

HGNC
LOCATION
7q36.1
LOCUSID
ALIAS
ERG-1,ERG1,H-ERG,HERG,HERG1,Kv11.1,LQT2,SQT1
FUSION GENES

Other Information

Locus ID:

NCBI: 3757
MIM: 152427
HGNC: 6251
Ensembl: ENSG00000055118

Variants:

dbSNP: 3757
ClinVar: 3757
TCGA: ENSG00000055118
COSMIC: KCNH2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000055118ENST00000262186Q12809
ENSG00000055118ENST00000262186A0A090N8Q0
ENSG00000055118ENST00000330883Q12809
ENSG00000055118ENST00000330883A0A090N7X5
ENSG00000055118ENST00000430723Q86U57

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90

Pathways

PathwaySourceExternal ID
Neuronal SystemREACTOMER-HSA-112316
Potassium ChannelsREACTOMER-HSA-1296071
Voltage gated Potassium channelsREACTOMER-HSA-1296072
Muscle contractionREACTOMER-HSA-397014
Cardiac conductionREACTOMER-HSA-5576891
Phase 3 - rapid repolarisationREACTOMER-HSA-5576890

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10202telithromycinChemicalVipGeneassociated16614168, 16278312
PA10407calcium channel blockersChemicalClinicalAnnotationassociatedPD
PA146096020nitrendipineChemicalClinicalAnnotationassociatedPD
PA159018367Brugada syndromeDiseaseDataAnnotationassociated
PA164784002sertindoleChemicalVipGeneassociated15718164, 16278312, 14999113
PA165817938prenylamineChemicalVipGeneassociated16278312
PA165817939pyrilamineChemicalVipGeneassociated16278312
PA165817950terodilineChemicalVipGeneassociated15718164, 16253929, 14999113
PA165818136Shortened QT intervalDiseaseVipGeneassociated12829173, 10862094
PA165818137lidoflazineChemicalVipGeneassociated15718164, 16278312, 14999113
PA166157289rs1137617VariantVipGeneassociated
PA166157308rs1805123VariantVipGeneassociated11997281, 12829173, 14499861, 14975928, 15746444, 17709632, 18222980, 10862094
PA166157459rs12720441VariantVipGeneassociated11997281
PA166157488rs36210421VariantVipGeneassociated14975928, 15522280, 17275752, 11468227
PA166183774short qt syndrome 1DiseaseClinicalAnnotationassociatedPD16842817
PA223KCNQ1GeneDataAnnotationassociated
PA25408BRAFGeneMultilinkAnnotationassociated26431495
PA304SCN5AGeneDataAnnotationassociated
PA444807Long QT SyndromeDiseaseVipGeneassociated14999113, 15522280, 15718164, 15746444, 17143043, 14499861
PA445787SyncopeDiseaseVariantAnnotationassociatedPD19057127
PA446294Torsades de PointesDiseaseClinicalAnnotation, VariantAnnotation, VipGeneassociatedPD14999113, 15522280, 15718164, 17143043, 11997281, 19057127
PA447184Romano-Ward SyndromeDiseaseDataAnnotationassociated
PA447288Essential hypertensionDiseaseClinicalAnnotationassociatedPD
PA447300Acquired Long QT Syndrome (aLQTS)DiseaseVariantAnnotation, VipGeneassociatedPD15522280, 15718164, 17143043, 14999113, 19057127
PA448383amiodaroneChemicalClinicalAnnotation, VipGeneassociatedPD14999113, 11997281
PA448498astemizoleChemicalVipGeneassociated14999113, 15718164, 16253929, 18701618, 10376921
PA449011cisaprideChemicalVariantAnnotation, VipGeneambiguous14999113, 15718164, 16253929, 18701618, 9374794, 14975928
PA449373disopyramideChemicalClinicalAnnotationassociatedPD16842817
PA449389dofetilideChemicalVariantAnnotation, VipGeneassociatedPK15522280, 18701618, 14999113, 15522280
PA449409doxepinChemicalVipGeneassociated
PA449422droperidolChemicalVipGeneassociated14999113
PA449493erythromycinChemicalVipGeneassociated16614168
PA449673fluoxetineChemicalVipGeneassociated11805215
PA449812grepafloxacinChemicalVipGeneassociated15718164, 16253929, 14999113
PA449841haloperidolChemicalVipGeneassociated16278312
PA449943hydroxyzineChemicalVariantAnnotation, VipGeneassociatedPD19057127
PA450215levomethadyl acetateChemicalVipGeneassociated15718164, 16253929, 14999113
PA450401methadoneChemicalVipGeneassociated17329992, 14999113
PA450492mibefradilChemicalVipGeneassociated16253929
PA450555moxifloxacinChemicalVipGeneassociated16614168
PA451107probucolChemicalVipGeneassociated15043509
PA451131propafenoneChemicalVipGeneassociated16278312
PA451209quinidineChemicalClinicalAnnotationassociatedPD16842817
PA451619terfenadineChemicalVipGeneassociated15718164, 16253929, 18701618, 14999113
PA451666thioridazineChemicalVipGeneassociated16278312

References

Pubmed IDYearTitleCitations
111366912001Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.322
193054082009Common variants at ten loci influence QT interval duration in the QTGEN Study.190
158404762005Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.177
229885942012hERG K(+) channels: structure, function, and clinical significance.166
146761482004Sudden death associated with short-QT syndrome linked to mutations in HERG.163
193054092009Common variants at ten loci modulate the QT interval duration in the QTSCD Study.162
164320672006Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.141
197160852009Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.126
197160852009Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.126
119972812002Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.125

Citation

Dessen P

KCNH2 (potassium voltage-gated channel subfamily H member 2)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45971/kcnh2